TABLE 3—
Number and Percentage of People With HIV Viral Suppression Among People Diagnosed Through 2008 and Living With HIV at the End of 2009: National HIV Surveillance System, 13 US Jurisdictions
| Among People With a VL Test |
VL ≤ 200 (Among Overall Population) |
VL ≤ 200 (Among People With a VL Test) |
||||||||
| Characteristic | Total,a No. (%b) | No. (%) | Geometric Mean VL | VL ≤ 200 No. | % | P | PRc (95% CI) | % | P | PRc (95% CI) |
| Sex | ||||||||||
| Male | 76 888 (76.6) | 40 578 (52.8) | 180 | 28 952 | 37.7 | 71.3 | ||||
| Female | 23 487 (23.4) | 13 064 (55.6) | 267 | 8256 | 35.2 | < .001 | 63.2 | < .001 | ||
| Age at end of 2008, y | ||||||||||
| 13–24 | 3672 (3.7) | 2102 (57.2) | 757 | 932 | 25.4 | 1.00 (Ref) | 44.3 | 1.00 (Ref) | ||
| 25–44 | 43 256 (43.1) | 23 386 (54.1) | 287 | 14 799 | 34.2 | < .001 | 1.25 (1.18, 1.32) | 63.3 | < .001 | 1.39 (1.33, 1.46) |
| 45–64 | 50 126 (49.9) | 26 650 (53.2) | 134 | 20 211 | 40.3 | < .001 | 1.51 (1.42, 1.59) | 75.8 | < .001 | 1.66 (1.58, 1.74) |
| ≥ 65 | 3321 (3.3) | 1504 (45.3) | 88 | 1266 | 38.1 | < .001 | 1.43 (1.33, 1.53) | 84.2 | < .001 | 1.77 (1.68, 1.86) |
| Race/ethnicity | ||||||||||
| Black | 44 410 (44.2) | 22 029 (49.6) | 335 | 13 269 | 29.9 | < .001 | 0.71 (0.70, 0.73) | 60.2 | < .001 | 0.82 (0.81, 0.83) |
| Hispanic | 12 181 (12.1) | 5660 (46.5) | 164 | 3981 | 32.7 | < .001 | 0.83 (0.81, 0.86) | 70.3 | < .001 | 0.93 (0.92, 0.95) |
| White | 40 188 (40.0) | 23 545 (58.6) | 131 | 18 218 | 45.3 | 1.00 (Ref) | 77.4 | 1.00 (Ref) | ||
| Otherd | 3596 (3.6) | 2408 (67.0) | 147 | 1740 | 48.4 | < .001 | 1.14 (1.10, 1.18) | 72.3 | < .001 | 0.96 (0.94, 0.99) |
| Transmission category | ||||||||||
| Male-to-male sexual contact | 44 359 (44.2) | 25 556 (57.6) | 158 | 18 950 | 42.7 | < .001 | 0.98 (0.96, 1.01) | 74.2 | < .001 | 1.07 (1.05, 1.09) |
| Injection drug use, males | 9949 (9.9) | 4230 (42.5) | 226 | 2749 | 27.6 | < .001 | 0.69 (0.66, 0.72) | 65.0 | .173 | 0.96 (0.93, 0.98) |
| Injection drug use, females | 5192 (5.2) | 2711 (52.2) | 302 | 1644 | 31.7 | < .001 | 0.79 (0.75, 0.83) | 60.6 | .004 | 0.92 (0.89, 0.95) |
| Male-to-male sexual contact and injection drug use | 6114 (6.1) | 3529 (57.7) | 215 | 2353 | 38.5 | .625 | 0.88 (0.85, 0.92) | 66.7 | .003 | 0.96 (0.94, 0.99) |
| Heterosexual contact,e males | 5924 (5.9) | 3116 (52.6) | 260 | 2044 | 34.5 | < .001 | 0.91 (0.88, 0.95) | 65.6 | .068 | 1.02 (0.99, 1.05) |
| Heterosexual contact,e females | 12 313 (12.3) | 7364 (59.8) | 257 | 4693 | 38.1 | 1.00 (Ref) | 63.7 | 1.00 (Ref) | ||
| Other/unknown, males | 10 542 (10.5) | 4147 (39.3) | 207 | 2856 | 27.1 | < .001 | 0.70 (0.68, 0.73) | 68.9 | < .001 | 1.06 (1.03, 1.08) |
| Other/unknown, females | 5982 (6.0) | 2989 (50.0) | 261 | 1919 | 32.1 | < .001 | 0.88 (0.84, 0.92) | 64.2 | .65 | 1.04 (1.01, 1.07) |
| Country of birth | ||||||||||
| United States | 72 669 (72.4) | 40 403 (55.6) | 214 | 27 843 | 38.3 | 1.00 (Ref) | 68.9 | 1.00 (Ref) | ||
| US dependency | 1283 (1.3) | 450 (35.1) | 212 | 295 | 23.0 | < .001 | 0.69 (0.63, 0.77) | 65.6 | .126 | 0.96 (0.90, 1.03) |
| Foreign country | 6527 (6.5) | 3191 (48.9) | 128 | 2349 | 36.0 | .000 | 0.97 (0.94, 1.01) | 73.6 | < .001 | 1.07 (1.04, 1.09) |
| Missing or unknown | 19 896 (19.8) | 9598 (48.2) | 162 | 6721 | 33.8 | < .001 | 0.93 (0.91, 0.95) | 70.0 | .034 | 1.01 (1.00, 1.03) |
| Total | 100 375 (100) | 53 642 (53.4) | 198 | 37 208 | 37.1 | 69.4 | ||||
Note. CI = confidence interval; PR = prevalence ratio; VL = viral load (copies/mL). The 13 US jurisdictions included were DE; Washington, DC; IA; IN; KY; MO; NE; NY [excluding New York City]; ND; San Francisco, CA; SC; WV; and WY. P values were determined by the χ2 test.
Because row totals for numbers were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
The total percentage represents the column percentage.
Calculated on the probability of having a suppressed VL (≤ 200 copies/mL) with multivariate binomial regression.
Multiple race, American Indian/Alaska Native, Asian, Native Hawaiian/Other Pacific Islander, and unknown race.
Heterosexual contact with person known to have or to be at high risk for HIV infection.